Teva Pharma (TEVA) Sinks 16% on Weak Results, Outlook
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) shares sink nearly 16% in pre-open trade following weak results and outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- US chip stocks gain after Apple-Intel partnership
- Regenxbio shares jump after FDA agrees to reverse drug rejection
Create E-mail Alert Related Categories
Earnings, Momentum Movers, Trader TalkRelated Entities
Pre Market MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
